SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-24-002206 from Advanced Health Intelligence Ltd (MYZQF) (CIK 0001815436)

Advanced Health Intelligence Ltd (MYZQF) (CIK 0001815436)
Date: Jan. 9, 2024 · CIK: 0001815436 · Accession: 0001213900-24-002206

AI Filing Summary & Sentiment

File numbers found in text: 001-41089

Date
January 9, 2024
Author
/s/ Simon Durack
Form
CORRESP
Company
Advanced Health Intelligence Ltd (MYZQF) (CIK 0001815436)

Letter

Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Re: Advanced Health Intelligence Ltd. Form 20-F for the Fiscal Year Ended June 30, File No. 001-41089

Dear Ms. Akst and Ms. Collins:

We note the receipt by Advanced Health Intelligence Ltd. (the “Company”) of the comment letter (the “Comment Letter”) dated December 18, 2023 from the staff (the “Staff”) of the Securities and Exchange Commission regarding the above-referenced Form 20-F.

In the Comment Letter you requested that the Company respond to your comments within ten business days or advise you when we would provide a response.

We would like to request an extension of an additional 10 business days to provide a response in order to gather information and ensure the completeness and accuracy of the Company’s response. Accordingly, the Company anticipates being able to provide a response to the Comment Letter by January 16, 2024.

Very truly yours,
/s/ Simon Durack

Show Raw Text
CORRESP
1
filename1.htm

Advanced Health Intelligence Ltd

71-73 South Perth Esplanade, Unit 5

South Perth, WA 6151

Australia

January 9, 2024

Megan Akst

Kathleen Collins

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Re:  Advanced Health
                                            Intelligence Ltd.

    Form 20-F for the Fiscal Year Ended June 30,
                                            2023

    File No. 001-41089

Dear Ms. Akst and Ms. Collins:

We note the receipt by Advanced Health Intelligence
Ltd. (the “Company”) of the comment letter (the “Comment Letter”) dated December 18, 2023 from the
staff (the “Staff”) of the Securities and Exchange Commission regarding the above-referenced Form 20-F.

In the Comment Letter you requested that the Company
respond to your comments within ten business days or advise you when we would provide a response.

We would like to request an extension of an additional
10 business days to provide a response in order to gather information and ensure the completeness and accuracy of the Company’s
response. Accordingly, the Company anticipates being able to provide a response to the Comment Letter by January 16, 2024.

    Very truly yours,

    /s/ Simon Durack

    Simon Durack

    Chief Financial Officer

cc:  Lawrence Metelitsa, Esq., Lucosky Brookman LLP